Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
A10BX08
CAS registry number (Chemical Abstracts Service)
0145375-43-5
Chemical Formula
C19-H25-N-O3
Molecular Weight
315
Therapeutic Category
Oral antidiabetic agent, meglitinide (glinide)
Chemical Names
(-)-(2S,3a,7a-cis)-α-benzylhexahydro-γ-oxo-2-isoindolinebutyric acid (WHO)
(2S)-2-benzyl-3-(cis-hexahydroisoindolin-2-ylcarbonyl)propionic acid
(2S)-2-benzyl-4-[(3aR,7aS)-octahydro-2H-isoindol- 2-yl]-4-oxobutanoic acid (IUPAC)
(αS,3aR,7aS)-Octahydro-γ-oxo-α-(phenylmethyl)-2H-isoindole-2-butanoic acid
Foreign Names
- Mitiglinidum (Latin)
- Mitiglinid (German)
- Mitiglinide (French)
- Mitiglinida (Spanish)
Generic Names
- UNII-D86I0XLB13 (IS)
- Mitiglinide Calcium Hydrate (OS: JAN)
- KAD-1229 (IS)
- Mitiglinde calcium dihydrate (IS)
- Mitiglinid hemicalcium-1-Wasser (IS)
- S-21403 (IS)
- V-2001 (IS)
Brand Names
- Glufast
Choong Wae Pharm, South Korea; Kissei, Japan
International Drug Name Search
Glossary
IUPAC | International Union of Pure and Applied Chemistry |
IS | Inofficial Synonym |
JAN | Japanese Accepted Name |
OS | Official Synonym |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
WHO | World Health Organization |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment